COMMUNIQUÉS West-GlobeNewswire
-
TALVEY®▼ (talquetamab) and DARZALEX® (daratumumab) subcutaneous (SC) formulation-based combination shows deep and durable responses in patients with relapsed or refractory multiple myeloma
27/09/2024 - 14:21 -
Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day
27/09/2024 - 14:30 -
Intelligent Bio Solutions Concludes In-Clinic Testing for Clinical Study Plan, Advancing Toward FDA 510(k) Submission
27/09/2024 - 14:30 -
Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering
27/09/2024 - 14:30 -
Burning Rock Announces Changes to Management and Board of Directors
27/09/2024 - 14:37 -
Turning Point of Tampa Now In-Network with Blue Cross Blue Shield Insurance
27/09/2024 - 15:00 -
Late-Breaking Data at EADV of ESK-001, an Oral TYK2 Inhibitor for the Treatment of Psoriasis, Demonstrate Significant Responses with Sustained Increases Over 28 Weeks in Phase 2 OLE Study
27/09/2024 - 15:00 -
Altamira Therapeutics Announces Extended ISO 13485 Quality Management System Certification for Bentrio Nasal Spray
27/09/2024 - 15:01 -
Communiqué de presse : Dupixent est le premier médicament biologique approuvé aux États-Unis pour le traitement de la BPCO
27/09/2024 - 15:35 -
Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD
27/09/2024 - 15:35 -
Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPD
27/09/2024 - 15:35 -
Cytokinetics Presents Additional Data from SEQUOIA-HCM at the HCMS Scientific Sessions
27/09/2024 - 17:00 -
Communities Across the Commonwealth Come Together to Celebrate Massachusetts Good Neighbor Day of Action
27/09/2024 - 18:15 -
DARZALEX® (daratumumab) subcutaneous (SC) formulation-based quadruplet regimen significantly improves minimal residual disease negativity for newly diagnosed multiple myeloma patients for whom transplant is not planned
27/09/2024 - 19:05 -
Neurona Therapeutics Announces Participation in Upcoming Investor Conferences in October
27/09/2024 - 20:00 -
PacBio Grants Equity Incentive Award to New Employee
27/09/2024 - 22:05 -
PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
27/09/2024 - 22:17 -
Les Données de l'Étude Pivot DREAM Présentées lors de l'International Surgical Sleep Society 2024 Educational Update
27/09/2024 - 22:30 -
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
27/09/2024 - 22:30
Pages